Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frovatriptan for Prevention of Difficult-to-Treat Menstrual Migraine
NCT00475514Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Oct 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of frovatriptan in migraine, sponsored by Endo International plc. Started Oct 2004; status: completed.
02
Drugs
frovatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00475514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475514.